Share on StockTwits

Analysts’ ratings reiterations for Wednesday, June 11th:

Armstrong World Industries (NYSE:AWI) had its underweight rating reiterated by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $53.00 price target on the stock, up from their previous price target of $51.00.

Brookfield Renewable Energy Partners (TSE:BEP.UN) had its sector perform rating reissued by analysts at National Bank Financial. The firm currently has a C$33.50 price target on the stock.

Big Lots (NYSE:BIG) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. They currently have a $46.00 price target on the stock, up from their previous price target of $45.00.

Banco Macro SA (NYSE:BMA) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. They currently have a $38.00 target price on the stock, up from their previous target price of $28.00.

Cabot Microelectronics (NASDAQ:CCMP) had its buy rating reissued by analysts at Topeka Capital Markets. Topeka Capital Markets currently has a $53.00 target price on the stock, up from their previous target price of $50.00.

CONSOL Energy (NYSE:CNX) had its neutral rating reaffirmed by analysts at Zacks. Zacks currently has a $49.00 price target on the stock. Zacks’ analyst wrote, “CONSOL Energy’s earnings per share and total revenues in the first quarter surpassed the Zacks Consensus Estimate. The year-over-year increase in revenue was primarily due to thriving natural gas and natural gas liquid sales. CONSOL Energy’s emphasis on natural gas assets has started to yield results. Consistent investments in natural gas projects will help the company to register a 30% jump in gas production over the next couple of years. Despite shifting its focus to natural gas, the company retains a few low-cost, high-quality coal mines. These assets will allow CONSOL Energy to tap the benefits from any rebound in coal demand either in the U.S. or in international markets. However, dependence on a limited group of customers for bulk sales and inherent risks associated with underground mining can somewhat offset the positives. We are maintaining our Neutral recommendation on the stock.”

Covanta Holding Corp (NYSE:CVA) had its outperform rating reiterated by analysts at Macquarie. They currently have a $25.00 price target on the stock, up from their previous price target of $21.00.

Chevron (NYSE:CVX) had its neutral rating reiterated by analysts at Zacks. They currently have a $132.00 target price on the stock. Zacks’ analyst wrote, “Chevron Corp. is one of the largest integrated energy companies in the world and has an impressive business model. Its current oil and gas development project pipeline is among the best in the industry, boasting large, multiyear projects. Additionally, Chevron possesses one of the healthiest balance sheets among peers, which helps it to capitalize on investment opportunities with the option to make strategic acquisitions. However, due to its integrated nature, Chevron is particularly susceptible to downside risk from any weakness in the global economy. We are also concerned by the company’s high level of capital spending, which may result in reduced returns going forward. As such, we see the stock performing in line with the broader market and maintain our Neutral recommendation. “

Dover Corp (NYSE:DOV) had its neutral rating reissued by analysts at Zacks. Zacks currently has a $94.00 price target on the stock. Zacks’ analyst wrote, “We have reiterated our Neutral recommendation on Dover Corporation with a target price of $94. Dover’s first-quarter 2014 adjusted earnings improved 9% year over year to $1.01 per share. Total revenue rose 7% to $1.9 billion, driven by organic growth and acquisitions. Dover will continue to benefit from its acquisitions, growth in bookings and orders and the Knowles spin off. Dover reitreated earnings in the range of $4.60-$4.80 per share for 2014 but expects revenue growth of 6% to 7%. A positive outlook for the semiconductor market is also likely to drive growth. However, volatile raw material costs and rising macroeconomic uncertainties might put margins under pressure.”

Foot Locker (NYSE:FL) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. They currently have a $51.00 target price on the stock, up from their previous target price of $50.00.

Francesca's Holdings Corp (NASDAQ:FRAN) had its buy rating reiterated by analysts at SunTrust. The firm currently has a $20.00 target price on the stock, down from their previous target price of $24.00.

Getty Realty Corp. (NYSE:GTY) had its underweight rating reaffirmed by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $16.00 target price on the stock, up from their previous target price of $14.00.

Hyatt Hotels (NYSE:H) had its neutral rating reaffirmed by analysts at Macquarie. Macquarie currently has a $65.00 target price on the stock, up from their previous target price of $60.00.

HD Supply Holdings (NYSE:HDS) had its outperform rating reissued by analysts at Raymond James. The firm currently has a $30.00 target price on the stock, up from their previous target price of $28.00.

HD Supply Holdings (NYSE:HDS) had its buy rating reaffirmed by analysts at SunTrust. They currently have a $34.00 price target on the stock, up from their previous price target of $29.00.

Henry Schein (NASDAQ:HSIC) had its neutral rating reaffirmed by analysts at Zacks. Zacks currently has a $126.00 target price on the stock. Zacks’ analyst wrote, “Henry Schein’s adjusted EPS of $1.18 in the first-quarter of 2014 increased 11.3% year over year and beat the Zacks Consensus Estimate by 4.4%. Revenues rose 6.1% to $2.43 billion, edging past the Zacks Consensus Estimate of $2.42 billion. Animal health continued to perform well while core dental business picked up. The recent strategic acquisitions are expected to add value to the business. With the animal health market growing at a rapid pace and showcasing favorable trends, we are confident about further sales improvement. However, the European economy and macroeconomic uncertainty remain as overhangs. Further, intense competition and currency fluctuations warrant caution. Moreover, as GPOs gain prominence, pricing pressure is inevitable. We still believe that the company’s diversified distribution business offers resilience against macroeconomic volatility. Thus, we remain Neutral on the stock. “

Altria Group (NYSE:MO) had its neutral rating reissued by analysts at Zacks. They currently have a $44.00 price target on the stock. Zacks’ analyst wrote, “Altria’s first-quarter 2014 earnings of $0.57 were in line with the Zacks Consensus Estimate. However, earnings were ahead of the year-ago results by 5.6% backed by strong performance of leading premium brands. Sales missed the Zacks Consensus Estimate by 1.0% as soft revenues in the Smokeable segment offset the gains in the smokeless segment. Overall, we are encouraged by the company’s efforts to adapt to the evolving consumer trends and develop less harmful alternative tobacco products. Also, we commend the company’s growing market share in the e-cigarette category. However, shift in demand from traditional tobacco products has led to declining volumes in the smokeable segment. Higher fees associated with litigations and the FDA’s anti-smoking campaigns are significant overhangs. Hence, we prefer to remain Neutral on the stock with a target price of $40.00.”

Performant Financial Corp (NASDAQ:PFMT) had its buy rating reiterated by analysts at SunTrust. They currently have a $11.75 price target on the stock, up from their previous price target of $10.75.

PVH Corp (NYSE:PVH) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. They currently have a $128.00 target price on the stock, down from their previous target price of $131.00.

ResMed (NYSE:RMD) had its neutral rating reaffirmed by analysts at Zacks. Zacks currently has a $55.00 price target on the stock. Zacks’ analyst wrote, “ResMed posted an unimpressive third-quarter fiscal 2014 with adjusted EPS of $0.63, which although grew 8.6%, was in line with the Zacks Consensus Estimate. Revenues of $397.8 million were up 3.7% but remained below the estimate of $399 million. ResMed continued to gain from a solid foothold in the huge SDB market and strong overseas business. Further penetration in the still untapped OSA market should catalyze growth. The company’s lucrative pipeline is another upside. Attractive share buyback continues to boost investors’ return. However, flat sales in the U.S. hampered growth. Besides, reimbursement issues across the world and competitive bid remain as major headwinds. The company also faces a tough competitive landscape and a challenging macroeconomic scenario. Thus, we remain Neutral on the stock.”

Science Applications International Corp. (NASDAQ:SAIC) had its overweight rating reissued by analysts at JPMorgan Chase & Co.. The firm currently has a $47.00 price target on the stock, up from their previous price target of $41.00.

Southwestern Energy Company (NYSE:SWN) had its neutral rating reiterated by analysts at Zacks. They currently have a $47.00 target price on the stock. Zacks’ analyst wrote, “We are reiterating our Neutral recommendation on Southwestern Energy following its stable first quarter 2014 results. The performance was backed by lower operating expenses and higher production, primarily at its Fayetteville shale operations. Going forward Southwestern Energy enjoys strong acreage positions in the Fayetteville and Marcellus shales, which offer ample opportunities for newer natural gas discoveries. The company’s effort to build its New Ventures acreage outside of New Brunswick is an added positive. Brown Dense is expected to be a key play in its portfolio. However, we prefer to stay on the sidelines, considering the volatile natural gas scenario in the U.S. Other risk factors include technological failures and the lack of a diversified asset base. “

Synaptics, (NASDAQ:SYNA) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $86.00 target price on the stock, up from their previous target price of $80.00.

TCF Financial (NYSE:TCB) had its neutral rating reaffirmed by analysts at Zacks. They currently have a $17.50 target price on the stock. Zacks’ analyst wrote, “TCF Financial’s first-quarter 2014 earnings came in line with the Zacks Consensus Estimate. However it came significantly above the prior-year quarter earnings. Organic growth was reflected in the quarter. Moreover, credit quality improved. However, increase in expenses was a headwind. We expect the company to maintain its superior position in the market based on its positive approach to market conditions and top-line growth. Moreover, a healthy capital position along with strong capital deployment activities is indicative of the company’s robust standing. However, regulatory pressure and continuous rise in expenses remain looming concerns.”

Texas Capital Bancshares (NASDAQ:TCBI) had its buy rating reissued by analysts at SunTrust. The firm currently has a $64.00 price target on the stock, down from their previous price target of $65.00.

Taubman Centers (NYSE:TCO) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. The firm currently has a $77.00 price target on the stock, up from their previous price target of $74.00.

T. Rowe Price Group (NASDAQ:TROW) had its neutral rating reissued by analysts at Zacks. The firm currently has a $88.00 price target on the stock. Zacks’ analyst wrote, “Riding on higher revenues, T. Rowe Price’s first-quarter 2014 net income beat the Zacks Consensus Estimate as well as significantly outperformed the year-ago earnings. Top-line growth and improved assets under management (AUM) were the tailwinds for the quarter. Moreover, the company exhibited a strong capital position. Yet, increased operating expenses acted as a dampener. We believe that the company’s financial stability has the potential to benefit from the growth opportunities in the domestic and global AUM. With a debt-free position, higher return on earnings, and improving investor sentiment witnessed as a whole, we believe fundamentals will continue to remain strong. However, higher operating expenses and stringent regulatory norms remain concerns. “

Waters (NYSE:WAT) had its neutral rating reaffirmed by analysts at Zacks. They currently have a $110.00 target price on the stock. Zacks’ analyst wrote, “We are reaffirming our Neutral recommendation on Waters Corporation with a target price of $110. The company reported weak first-quarter results with decline in both the top and bottom lines. In the quarter the company’s business was primarily impacted by unfavorable currency translation and a combination of slow growth in Asia and delay in releasing capital budgets in the U.S. However, Waters benefits from newer core offerings in chromatography, mass spectrometry and thermal technologies. Nevertheless, weakness affecting pharmaceutical end markets and currency fluctuations remains a matter of concern for the company.”

Washington Real Estate Investment Trust (NYSE:WRE) had its underweight rating reissued by analysts at JPMorgan Chase & Co.. The firm currently has a $26.00 price target on the stock, up from their previous price target of $23.00.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.